Stay updated on Clinical Trial: HaploNK Cells for Neuroblastoma/Osteosarcoma

Sign up to get notified when there's something new on the Clinical Trial: HaploNK Cells for Neuroblastoma/Osteosarcoma page.
Latest website image capture
Clouds background image

Latest updates to the Clinical Trial: HaploNK Cells for Neuroblastoma/Osteosarcoma page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page now displays a newer site revision/version number (v3.5.3 instead of v3.5.2) while the underlying record history content remains the same.
    Difference
    0.1%
    Check dated 2026-04-24T05:51:17.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2. Deleted Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:34:54.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    50 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T04:49:25.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    Added a new revision entry v3.4.3 and removed the previous revision v3.4.2 from the history.
    Difference
    0.1%
    Check dated 2026-03-12T00:27:55.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    Visual/layout updates to the Record History page; core study data and identifiers appear unchanged.
    Difference
    0.1%
    Check dated 2026-02-25T19:04:56.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    A new revision entry v3.4.2 was added to the history and older funding notices were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.7%
    Check dated 2026-02-11T11:30:19.000Z thumbnail image

Stay in the know with updates to Clinical Trial: HaploNK Cells for Neuroblastoma/Osteosarcoma

Enter your email address, and we'll notify you when there's something new on the Clinical Trial: HaploNK Cells for Neuroblastoma/Osteosarcoma page.